Exane Derivatives Qiagen N.V. Call Options Transaction History

Exane Derivatives

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Jan 31, 2019	SELL	$32.65 - $37.95 $97,950 - $113,850	-3,000 Closed	0 $0
Q2 2018 Oct 24, 2018	SELL	$31.23 - $37.47 $2,092 - $2,510	-67 Reduced 2.18%	3,000 $0
Q2 2018 Jul 19, 2018	BUY	$31.23 - $37.47 $79,698 - $95,623	2,552 Added 495.53%	3,067 $0
Q1 2018 Oct 24, 2018	SELL	$31.01 - $34.72 $29,862 - $33,435	-963 Reduced 65.16%	515 $0
Q1 2018 Apr 30, 2018	BUY	$31.01 - $34.72 $12,931 - $14,478	417 Added 39.3%	1,478 $0
Q4 2017 Jan 29, 2018	SELL	$30.68 - $35.37 $6,872 - $7,922	-224 Reduced 17.43%	1,061 $0
Q3 2017 Oct 18, 2017	BUY	$31.02 - $32.94 $39,860 - $42,327	1,285	1,285 $0

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.89B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.